In case you missed any, read a recap of the episodes of OncLive On Air that aired in July 2026.
Related to this article
Faculty convened for a virtual OncLive Scientific Interchange and Workshop to interpret emerging trial data and treatment strategies for systemic mastocytosis.
Antibodies directed against TNFR2, a regulator in the tumor microenvironment that promotes tumor cell proliferation, have shown promise in T-cell lymphoma and ovarian cancer.
The FDA approved RP1 plus nivolumab in advanced melanoma, granted olomorasib breakthrough status in KRAS G12C+ pancreatic cancer, and more.
Advertisement
Advertisement
Trending on OncLive
1
Enzalutamide Plus Talazoparib Shows Activity in mHSPC
2
European Commission Approves Teclistamab Plus Daratumumab for R/R Myeloma
3
ASCO Issues First Guideline on ctDNA Testing in Solid Tumors and Lymphoma
4
FDA Approves First CELMoD Agent, With Dana-Farber Helping Advance Its Development
5